Insider · CIK 0002007101
Arthur Kuan
ceoofficerdirector
Files at CGON (CG Oncology, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | CGON CG Oncology, Inc. | MOption exercise Common Stock | +64,612 | $1.72 | $111k | 200,763 | Mar 13, 2026 |
| Mar 12, 2026 | CGON CG Oncology, Inc. | FTax withholding Common Stock | -1,847 | $60.15 | $111k | 198,916 | Mar 13, 2026 |
| Mar 12, 2026 | CGON CG Oncology, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -64,612 | $0.00 | $0 | 0 | Mar 13, 2026 |
| Mar 4, 2026 | CGON CG Oncology, Inc. | MOption exercise Common Stock | +102,871 | $1.72 | $177k | 139,022 | Mar 6, 2026 |
| Mar 4, 2026 | CGON CG Oncology, Inc. | FTax withholding Common Stock | -2,871 | $61.61 | $177k | 136,151 | Mar 6, 2026 |
| Mar 4, 2026 | CGON CG Oncology, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -102,871 | $0.00 | $0 | 64,612 | Mar 6, 2026 |
| Apr 15, 2025 | CGON CG Oncology, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +527,660 | $0.00 | $0 | 527,660 | Apr 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.